Author

Ayan Chatterjee

University of MissouriPrimary ORCID profile (0000-0002-8662-4863 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ayan ChatterjeeiD3 papers · Northeastern University

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:metagenomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

André Mendes Ribeiro Corrêa· 1 shared Anil KumariD· 1 shared Arul Jayaraman· 1 shared Arum HaniD· 1 shared Bennett Flannagan· 1 shared Cansu Ağca· 1 shared Cassian YeeiD· 1 shared Christina James Thomas· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

André Mendes Ribeiro Corrêa

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Synthetic Microbial Therapy Rewires Antitumor Immunity Across Multiple Cancer Types

Jugal Kishore Das, Qing‐Ming Qin, Shailbala Singh, Christina James Thomas, Shreyan Gupta, Ayan Chatterjee, Sunilgowda Sunnagatta Nagaraja, Fengguang Guo, Kaylee Delgado, Anil Kumar, Esther Ryu, Bennett Flannagan, Cansu Ağca, Yüksel Ağca, Noah Powell, , Paul de Figueiredo

This paper introduces a synthetic microbial therapy that enhances antitumor immunity across multiple cancer types in mice, showing durable responses and synergy with chemotherapy.

bioRxiv · Jul 22, 2026 · PreprintImmunology